Geron Corporation

CompanyUnited StatesFounded 1990

RORWikidata

Geron Corporation develops 2 assets, the furthest approved (Imetelstat in myelodysplastic syndrome). Mostly oligonucleotide acting on TERT; based in the United States, founded in 1990.

2
Assets
Furthest stage
Approved
16
Trials
6
Signals

Pipeline

2
  • Imetelstat

    Inhibits telomerase, depriving cancer cells of continued growth and survival.

    Approved, Oligonucleotide, TERT, myelodysplastic syndrome, anemia

  • IMpactMF

    Telomerase inhibitor

    Phase 3, Oligonucleotide, myelofibrosis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials23
  • Deals9
  • People17
  • Signals10
  • Similar companies6

Papers

Intelligence